155 related articles for article (PubMed ID: 9003344)
1. Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide.
Danis RP; Bingaman DP; Yang Y; Ladd B
Ophthalmology; 1996 Dec; 103(12):2099-104. PubMed ID: 9003344
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of intraocular neovascularization caused by retinal ischemia in pigs by PKCbeta inhibition with LY333531.
Danis RP; Bingaman DP; Jirousek M; Yang Y
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):171-9. PubMed ID: 9430559
[TBL] [Abstract][Full Text] [Related]
3. Regression of optic nerve head neovascularization in proliferative diabetic retinopathy after intravitreal triamcinolone. Regression of diabetic optic disc neovascularization after intravitreal triamcinolone.
Karacorlu M; Ozdemir H; Karacorlu S; Alacali N
Int Ophthalmol; 2004 Mar; 25(2):113-6. PubMed ID: 15290890
[TBL] [Abstract][Full Text] [Related]
4. Preretinal and optic nerve head neovascularization induced by photodynamic venous thrombosis in domestic pigs.
Danis RP; Yang Y; Massicotte SJ; Boldt HC
Arch Ophthalmol; 1993 Apr; 111(4):539-43. PubMed ID: 7682408
[TBL] [Abstract][Full Text] [Related]
5. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M
Retina; 2007; 27(9):1201-4. PubMed ID: 18046225
[TBL] [Abstract][Full Text] [Related]
6. The effects of intravitreal triamcinolone acetonide on experimental pre-retinal neovascularization.
Antoszyk AN; Gottlieb JL; Machemer R; Hatchell DL
Graefes Arch Clin Exp Ophthalmol; 1993; 231(1):34-40. PubMed ID: 8428678
[TBL] [Abstract][Full Text] [Related]
7. [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].
Jonas JB; Kreissig I; Kamppeter B; Degenring RF
Ophthalmologe; 2004 Feb; 101(2):113-20. PubMed ID: 14991306
[TBL] [Abstract][Full Text] [Related]
8. Effect of triamcinolone acetonide on vascular endothelial growth factor and occludin levels in branch retinal vein occlusion.
McAllister IL; Vijayasekaran S; Chen SD; Yu DY
Am J Ophthalmol; 2009 May; 147(5):838-46, 846.e1-2. PubMed ID: 19211093
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
Jonas JB
Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
[TBL] [Abstract][Full Text] [Related]
10. Preretinal neovascularization induced by experimental retinal vein occlusion in albino rats.
Ham DI; Chang K; Chung H
Korean J Ophthalmol; 1997 Jun; 11(1):60-4. PubMed ID: 9283155
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide].
Jonas JB; Kreissig I; Degenring RF
Klin Monbl Augenheilkd; 2003 Jun; 220(6):384-90. PubMed ID: 12830391
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal triamcinolone acetonide: a change in a paradigm.
Jonas JB
Ophthalmic Res; 2006; 38(4):218-45. PubMed ID: 16763379
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.
Hayashi K; Hayashi H
Am J Ophthalmol; 2005 Jun; 139(6):972-82. PubMed ID: 15953425
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal triamcinolone acetonide for treatment of persistent macular oedema in branch retinal vein occlusion.
Ozkiris A; Evereklioglu C; Erkilic K; Dogan H
Eye (Lond); 2006 Jan; 20(1):13-7. PubMed ID: 15723039
[TBL] [Abstract][Full Text] [Related]
15. Effect of photodynamic therapy alone or combined with posterior subtenon triamcinolone acetonide or intravitreal bevacizumab on choroidal hypofluorescence by indocyanine green angiography.
Hatta Y; Ishikawa K; Nishihara H; Ozawa S; Ito Y; Terasaki H
Retina; 2010 Mar; 30(3):495-502. PubMed ID: 19996828
[TBL] [Abstract][Full Text] [Related]
16. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
Patel PJ; Zaheer I; Karia N
Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic response to intravitreal triamcinolone in eyes with macular edema: intravitreal triamcinolone and ocular blood flow.
Cekiç O; Bardak Y; Tiğ SU; Demirkol A; Ekim MM; Altintaş O; Yeşildağ A; Oyar O
Int Ophthalmol; 2007 Oct; 27(5):313-9. PubMed ID: 17505781
[TBL] [Abstract][Full Text] [Related]
19. Effect of triamcinolone acetonide on proliferation of retinal endothelial cells in vitro and in vivo.
Spandau UH; Sauder G; Schubert U; Hammes HP; Jonas JB
Br J Ophthalmol; 2005 Jun; 89(6):745-7. PubMed ID: 15923512
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection.
Im L; Allingham RR; Singh I; Stinnett S; Fekrat S
J Glaucoma; 2008 Mar; 17(2):128-32. PubMed ID: 18344759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
